An open-label international multicentric phase II study of nilotinib in progressive pigmented villo-nodular synovitis (PVNS) not amenable to a conservative surgical treatment.
Үндсэн зохиолчид: | , , , , , , , , , , , , , , , , , , |
---|---|
Формат: | Journal article |
Хэвлэсэн: |
2013
|
Тойм: |
---|